In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
With the introduction of oral GLP-1s (short for glucagon-like peptide-1), theres now a convenient, needle-free option for weight loss and type 2 diabetes management
Lilly "absolutely" plans to make the drug available there, Ricks said
Zepbound (Injectable) Zepbound (tirzepatide) injectable, a FDA-approved dual GIP and GLP-1 receptor agonist, taken once a week using single use vials and insulin syringes
However, both medications have been shown to be safe and effective tools for weight management when used under medical supervision
RELATED : These 14 Stars Are Transcending the Pain of Endometriosis Diagnosis of Menstrual PeriodRelated Problems The most important issue in a medical evaluation is your personal history, where your doctor will ask about your past and present health conditions, any medications you take (especially birth control), and your menstrual history